RAER Therapeutics
PrivateLast Round
Accelerator
Sep 26, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
RAER Therapeutics is a biotechnology company that develops innovative therapies for rare genetic diseases using a rapid, cost-effective screening platform.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RAER Therapeutics Comparables
Compare RAER Therapeutics with similar companies based on industry and business-model similarity.
RAER Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Sep 26, 2025 |
RAER Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| P4 Precision Medicine Accelerator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 26, 2025
Secured funding from P4 Precision Medicine Accelerator.
RAER Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about RAER Therapeutics's valuation, stock price, and market status.